ARDELYX, INC. (ARDX) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-30

Key Insights

Ardelyx announced Q1 2026 financial results on April 30, 2026, indicating the company is actively reporting operational performance to investors through standard earnings disclosure procedures.
The company hosted a conference call with an earnings presentation (Exhibit 99.2) to discuss Q1 2026 results, suggesting management engagement with investors and analysts regarding business performance and strategy.
The filing was signed by Susan Hohenleitner, Chief Financial Officer, indicating proper corporate governance and authorization of financial disclosures.

Want the newest filings?

This analysis covers the filing from 2026-04-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-08

Ardelyx reported strong net product sales for IBSRELA ($87 million in Q4 2025, $274 million for full year 2025) and XPHOZAH ($28 million in Q4 2025, $104 million for full year 2025), indicating successful commercialization of its key products.
The company had a healthy cash, cash equivalents, and short-term investments balance of approximately $265 million as of December 31, 2025, suggesting financial stability and the ability to fund ongoing operations.
The preliminary financial data provided is unaudited, so investors should await the company's audited financial statements for the full year 2025 to get a complete picture of the financial performance.

Other reports for ARDELYX, INC.

Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.